Xcout Intel
DJS Antibodies competitors & alternatives
The 12 closest competitors and alternatives to DJS Antibodies among biotechnology companies — ranked by similarity to what DJS Antibodies actually does, not by market-cap band.
Subscribe to see DJS Antibodies’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About DJS Antibodies
DJS Antibodies is an Oxford-based biotechnology research company operating on the cutting edge of drug discovery and development, and is now a part of AbbVie.
DJS Antibodies at a glance
DJS Antibodies is a biotechnology company headquartered in United Kingdom, founded in 2014. Its most recent funding round, Seed, raised $2.7M in June 2024.
DJS Antibodies funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $2.7M | 5 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 DJS Antibodies competitors
Ranked by semantic similarity — how close each company is to DJS Antibodies by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Life Sciences
KisoJi Biotechnology Inc. is a drug discovery company headquartered in Montreal, Canada, utilizing a proprietary antibody discovery platform to create next-generation antibody drugs.
Biotech
AbCellera is a biotechnology company that integrates biology, computation, and engineering to discover and develop antibody-based medicines. The company operates a proprietary technology platform to advance internal and partnered drug programs across therapeutic areas such as endocrinology, immunology, autoimmunity, and oncology.
Similar biotechnology company
Dark Blue Therapeutics is an innovative drug discovery biotechnology company based in Oxford, United Kingdom, focused on early oncology research before being acquired by Amgen.
Biotech
Antiverse is a biotechnology research company headquartered in Cardiff, Wales, that utilizes generative artificial intelligence to design functional antibodies for challenging drug targets.
Similar biotechnology company
AbbraTech Holdings LLC operates a platform technology focused on recombinant antibody discovery, engineering, and validation. The company targets human diseases such as cancer, immune disorders, and viral infections by developing antibodies for difficult-to-reach drug targets through its proprietary Epivolve technology.
Biotech
Ditto Biosciences is a company headquartered in San Francisco, US, that focuses on drug discovery. The company is involved in identifying proteins that could lead to new drugs for patients with autoimmune diseases.
Similar biotechnology company
Affibody AB is a Swedish biopharmaceutical company located in Solna that develops next-generation biopharmaceuticals based on its proprietary Affibody technology platform.
Similar biotechnology company
Adimab is a biotechnology research company headquartered in Lebanon, New Hampshire, that serves as a biopharmaceutical industry partner for therapeutic antibody discovery and engineering.
Similar biotechnology company
Evolved Therapeutics is a life sciences company headquartered in Vancouver, British Columbia, operating in the antibody discovery sector. The organization focuses on establishing innovative function-first antibody discovery platforms.
Biotech
Inventisbio is a biopharmaceutical company that focuses on the discovery and development of innovative drugs for major diseases such as tumors, autoimmune diseases, and metabolic disorders. Utilizing an independent research and development platform, the company creates proprietary drug pipelines targeting oncology drivers, kinases, and autoimmune pathways to serve patients globally.
Similar biotechnology company
Perseus Proteomics Inc. is a Japanese biotechnology company focused on antibody drug discovery and research support. The firm develops novel therapeutic antibody drugs for cancer and other diseases utilizing its proprietary antibody technologies.
Biotech
OmniAb, Inc. is an American biotechnology firm focused on pioneering therapeutic antibody discovery. The company provides a sophisticated platform that allows its industry partners to access a broad spectrum of antibody repertoires and advanced screening techniques, thereby facilitating the development of next-generation treatments. Central to the OmniAb platform is the unique biological capability of proprietary genetically engineered animals, such as OmniRat, OmniChicken, and OmniMouse. These animals are modified to produce human-sequence antibodies, simplifying the creation of human therapeutic candidates. Additionally, OmniAb offers specialized technologies like OmniFlic (a transgenic rat) and OmniClic (a transgenic chicken), which address the requirements for bispecific antibody applications via a common light chain method, as well as OmniTaur, which leverages the distinct structural properties of cow antibodies for challenging targets. The company was founded in 2012 and is based in Emeryville, California.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of DJS Antibodies and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for DJS Antibodiesand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →